443 related articles for article (PubMed ID: 18471160)
1. Efficacy of caspofungin in invasive candidiasis and candidemia--de-escalation strategy.
Lichtenstern C; Nguyen TH; Schemmer P; Hoppe-Tichy T; Weigand MA
Mycoses; 2008; 51 Suppl 1():35-46. PubMed ID: 18471160
[TBL] [Abstract][Full Text] [Related]
2. Candida and candidaemia. Susceptibility and epidemiology.
Arendrup MC
Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
[TBL] [Abstract][Full Text] [Related]
3. Caspofungin therapy of neonates with invasive candidiasis.
Odio CM; Araya R; Pinto LE; Castro CE; Vasquez S; Alfaro B; Sàenz A; Herrera ML; Walsh TJ
Pediatr Infect Dis J; 2004 Dec; 23(12):1093-7. PubMed ID: 15626944
[TBL] [Abstract][Full Text] [Related]
4. New options for treatment of candidaemia in critically ill patients.
Ruhnke M; Hartwig K; Kofla G
Clin Microbiol Infect; 2008 May; 14 Suppl 4():46-54. PubMed ID: 18430129
[TBL] [Abstract][Full Text] [Related]
5. Increasing incidence of Candida parapsilosis candidemia with caspofungin usage.
Forrest GN; Weekes E; Johnson JK
J Infect; 2008 Feb; 56(2):126-9. PubMed ID: 18082269
[TBL] [Abstract][Full Text] [Related]
6. Seven-year trend analysis of nosocomial candidemia and antifungal (fluconazole and caspofungin) use in Intensive Care Units at a Brazilian University Hospital.
Girão E; Levin AS; Basso M; Gobara S; Gomes LB; Medeiros EA; Costa SF
Med Mycol; 2008 Sep; 46(6):581-8. PubMed ID: 19180727
[TBL] [Abstract][Full Text] [Related]
7. Comparison of caspofungin and amphotericin B for invasive candidiasis.
Mora-Duarte J; Betts R; Rotstein C; Colombo AL; Thompson-Moya L; Smietana J; Lupinacci R; Sable C; Kartsonis N; Perfect J;
N Engl J Med; 2002 Dec; 347(25):2020-9. PubMed ID: 12490683
[TBL] [Abstract][Full Text] [Related]
8. Catheter-related candidemia caused by Candida haemulonii in a patient in long-term hospital care.
Kim S; Ko KS; Moon SY; Lee MS; Lee MY; Son JS
J Korean Med Sci; 2011 Feb; 26(2):297-300. PubMed ID: 21286025
[TBL] [Abstract][Full Text] [Related]
9. [Therapy of candidemia and invasive candidiasis according to guidelines].
Glöckner A
Mycoses; 2010 May; 53 Suppl 1():30-5. PubMed ID: 20433654
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of micafungin in invasive candidiasis caused by common Candida species with special emphasis on non-albicans Candida species.
Cornely OA; Vazquez J; De Waele J; Betts R; Rotstein C; Nucci M; Pappas PG; Ullmann AJ
Mycoses; 2014 Feb; 57(2):79-89. PubMed ID: 23786573
[TBL] [Abstract][Full Text] [Related]
11. Epidemiology and outcomes of candidemia in 2019 patients: data from the prospective antifungal therapy alliance registry.
Horn DL; Neofytos D; Anaissie EJ; Fishman JA; Steinbach WJ; Olyaei AJ; Marr KA; Pfaller MA; Chang CH; Webster KM
Clin Infect Dis; 2009 Jun; 48(12):1695-703. PubMed ID: 19441981
[TBL] [Abstract][Full Text] [Related]
12. Global distribution and outcomes for Candida species causing invasive candidiasis: results from an international randomized double-blind study of caspofungin versus amphotericin B for the treatment of invasive candidiasis.
Colombo AL; Perfect J; DiNubile M; Bartizal K; Motyl M; Hicks P; Lupinacci R; Sable C; Kartsonis N
Eur J Clin Microbiol Infect Dis; 2003 Aug; 22(8):470-4. PubMed ID: 12884068
[TBL] [Abstract][Full Text] [Related]
13. Candida dubliniensis meningitis as delayed sequela of treated C. dubliniensis fungemia.
van Hal SJ; Stark D; Harkness J; Marriott D
Emerg Infect Dis; 2008 Feb; 14(2):327-9. PubMed ID: 18258133
[TBL] [Abstract][Full Text] [Related]
14. Invasive candidiasis in cancer patients: observations from a randomized clinical trial.
DiNubile MJ; Hille D; Sable CA; Kartsonis NA
J Infect; 2005 Jun; 50(5):443-9. PubMed ID: 15907554
[TBL] [Abstract][Full Text] [Related]
15. Successful treatment with caspofungin of refractory Candida krusei candidemia in a very low birth weight preterm infant.
Natale F; Castronovo A; Regoli D; De Curtis M; Manzoni P
Pediatr Infect Dis J; 2009 May; 28(5):452. PubMed ID: 19295457
[No Abstract] [Full Text] [Related]
16. Development of candidemia on caspofungin therapy: a case report.
Cheung C; Guo Y; Gialanella P; Feldmesser M
Infection; 2006 Dec; 34(6):345-8. PubMed ID: 17180591
[TBL] [Abstract][Full Text] [Related]
17. Caspofungin in combination with amphotericin B against Candida glabrata.
Barchiesi F; Spreghini E; Fothergill AW; Arzeni D; Greganti G; Giannini D; Rinaldi MG; Scalise G
Antimicrob Agents Chemother; 2005 Jun; 49(6):2546-9. PubMed ID: 15917570
[TBL] [Abstract][Full Text] [Related]
18. [Echinocandins in invasive candidiasis].
Glöckner A; Cornely OA
Med Klin (Munich); 2008 Jun; 103(6):397-405. PubMed ID: 18548209
[TBL] [Abstract][Full Text] [Related]
19. Breakthrough Candida krusei fungemia during fluconazole prophylaxis followed by breakthrough zygomycosis during caspofungin therapy in a patient with severe aplastic anemia who underwent stem cell transplantation.
Girmenia C; Moleti ML; Micozzi A; Iori AP; Barberi W; Foà R; Martino P
J Clin Microbiol; 2005 Oct; 43(10):5395-6. PubMed ID: 16208029
[TBL] [Abstract][Full Text] [Related]
20. Successful treatment of an infant infected with refractory C. parapsilosis with caspofungin.
Ozkaya-Parlakay A; Tezer H; Kazmacan T; Gulhan B; Unal S
J Trop Pediatr; 2014 Aug; 60(4):329-30. PubMed ID: 24567311
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
